Assessment of major gaps from the perspective of patients, patient advocates and NET health care professionals.
Due to the increasing incidence and prevalence of neuroendocrine tumors (NETs), there is a need to assess any gaps in awareness and care. A survey was undertaken in 2017 to identify perceived unmet needs from the perspectives of patients/families, patient advocates and health care professionals (HCPs). The survey consisted of 33–37 questions (depending on type of respondent) across four areas: information, care, treatments and research.
Recent News
NHS Health and exercise commonwealth campaign
The Commonwealth Games 2022 has proven to be one of the most successful ever held, with more than 5,000 athletes from 72 nations competing in 19 different sports. The Games have now concluded, and the baton has been passed on to Australia. However, the legacy of being...
NHS-Galleri Trial
In July NHS chief executive Amanda Pritchard announced the latest milestone in NHS cancer innovation with an update on the NHS-Galleri trial (the blood test that potentially offers earlier detection of hard to spot cancers, even before symptoms appear). Over 140,000...
Pamela L. Kunz, MD, on Pancreatic Neuroendocrine Tumors
ASCO News on CapTem chemotherapy trial Associate Professor Pamela L. Kunz*, MD, of the Yale University School of Medicine, discusses new findings from the ECOG-ACRIN E2211 trial (ClinicalTrials.gov Identifier: NCT01824875): Temozolomide With or Without Capecitabine in...